New data from IM1240 (capped-CD3 × 5T4 × NKG2A) tri-specific antibody demonstrated potent anti-tumor activity across all treatment-resistant ...

Approved for use before surgery based on DESTINY-Breast11 phase 3 trial or following surgery based on DESTINY-Breast05 phase 3 trial. Two new indications bring Daiichi Sankyo and ...

The news of a stage 4 breast cancer diagnosis can make one feel as if the world has been turned upside down. For many, the ...

Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary and metastatic ...

"Now, we feel like we can finally start to move ahead with the married life we had planned," Sean Scanlon told PEOPLE ...

NEO-CYT marks the first evaluation of MDNA11 in earlier-stage cancers, as a potentially curative treatment; extends development beyond the ...

Kiersten Dyke, 25, died on 26 April after a years-long battle with melanoma skin cancer that she documented publicly on TikTok, just weeks after her oncologist told her she had only months to live ...

Her boyfriend of nearly 9 years, Dominic Cinfio, confirmed the news of her death with posts on social media ...

Discusses Extended Follow-Up Data From Phase 3 Trial of aglatimagene besadenovec in Localized Prostate Cancer May 15, ...

Every single type of cancer, explained A cancer diagnosis can be both terrifying and confusing for those afflicted, as well ...

But it got to the point where, if the pain came on when I was having a conversation, I couldn’t concentrate on what was being ...

Spago Nanomedical AB (publ) announced today that the independent Data Monitoring Committee (DMC) of the Tumorad-01 study declared that a primary endpoint, identifying the maximum tolerated dose, has ...